George M Jenkins insider trades: Palvella Therapeutics (PVLA) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where George reports to the SEC
Open-market buys and sales
7 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Oct 14, 2026 | PVLA | ↓ Sell | 27,500 | $130.16 | $3.6M | Direct | Oct 14, 2026 (0d) |
| Sep 15, 2026 | PVLA | ↓ Sell | 27,500 | $151.53 | $4.2M | Direct | Sep 15, 2026 (0d) |
| Mar 30, 2026 | PVLA | ↑ Buy | 445 | $112.30 | $50K | Direct | Apr 1, 2026 (2d) |
| Feb 27, 2026 | PVLA | ↑ Buy | 4,000 | $125.00 | $500K | Direct | Mar 2, 2026 (3d) |
| Apr 9, 2025 | PVLA | ↑ Buy | 2,490 | $20.27 | $50K | by foundation | Apr 10, 2025 (1d) |
| Apr 9, 2025 | PVLA | ↑ Buy | 2,500 | $20.13 | $50K | Direct | Apr 10, 2025 (1d) |
| Dec 18, 2024 | PVLA | ↑ Buy | 4,000 | $12.93 | $52K | Direct | Dec 19, 2024 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other PVLA insiders
Open-market trades in the last 12 months
About George M Jenkins's insider trades
George M Jenkins is a director at Palvella Therapeutics (PVLA). Since Dec 18, 2024, George has reported 5 open-market purchases worth $702K and 2 sales worth $7.7M on SEC Form 4. In the last 12 months: 2 buys ($550K) and 2 sales ($7.7M).
Their filings also include grants and awards (3 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every PVLA insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.